Abstract:Objective: To investigate the efficacy of CT-guidance interstitial Iodine-125 seed brachytherapy as a salvage therapy for recurrent head and neck carcinoma. Methods: A total of 122 patients who had been treated for recurrent head and neck carcinoma with CT-guided Iodine-125 seed permanent implantation were conducted a retrospective analysis at Peking University Third Hospital from February 2003 to December 2015. The study included 78 male and 44 female patients. Of the 122 patients, 76 had undergone radical surgery, 106 had received EBRT. Among the patients who underwent EBRT, the total dose delivered to PTV ranged from 30 to 140 Gy (median, 68.4 Gy). The actuarial median number of the implanted Iodine-125 seeds was 38 (range, 5-158). The specific activity of Iodine-125 seeds ranged from 14.8 to 28.9 MBq/seed (median, 22.2 MBq). The evaluation of post plan showed the actuarial D90 ranged from 46 to 282 Gy (median, 121 Gy). The overall local control and survival times were determined by using the Kaplan-Meier method from SPSS 13.0.Univariate analysis was performed on the local control rate and overall survival rate. Results: Tumor responses rate was 75.4%. The median local control time was 10.0 months (95% CI 9.8-24.2 months), and the 1-, 2-, 3-, and 5-year local control were 41.9%, 21.2%, 3.7%, and 3.7%, respectively. Univariate analysis showed that the local control in D90≥120 Gy group had an increasing tendency, but no statistical difference were found. The effect of local control in the squamous cell carcinoma group was slightly worse than that in the non-squamous cell carcinoma group (P=0.032). Multi-factor analysis showed that the effect of local control in the squamous cell carcinoma group was slightly poor (P=0.03). The median survival time was 14 months (95% CI 14.4-35.8 months), and the 1-, 2-, 3- and 5-year survival rate were 51.5%, 34.2%, 19.4%, and 19.4%, respectively. The three factors, such as the tumor responses, KPS status before the seed implantation, and the D90 after the seed implantation, had a tendency to improve the total survival, but there was still no statistical differences. Multivariate analysis showed no clear influence factors. Conclusions: Interstitial permanent Iodine-125 seed implantation is an effective salvage re-irradiation modality for recurrent head and neck carcinoma after previous surgery and/or EBRT. CT image-guided method could yield the reliable seeds configuration and accurate dose distribution.

Clinical Effect of Iodine 125 Seeds Implantation Synchronized Chemotherapy with Docetaxel, ;Cisplatin,5-Fluorouracil for Unresectable Head and Neck Squamous Cell Carcinoma

Efficacy of Brachytherapy Concomitant with Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil in Unresectable Head and Neck Squamous Cell Carcinoma.

Effects Of Radioactive Iodine-125 Seed Implantation On Therapeutic Efficacy, Serum Vegf, Cea Levels, And Prognosis Of Patients With Ocular Malignant Tumors

External Beam Radiation Therapy Combined with Individual Template Assisted Iodine125 Radioactive Seed Implant for Head and Neck Squamous Cell Carcinoma

Clinical Efficacy of CT-guided Iodine-125 Seed Implantation for Recurrent Head and Neck Carcinoma after External Beam Radiotherapy

The efficacy and safety of <SUP>125</SUP>I brachytherapy combined with pre-operative transarterial chemoembolization in patients with locally advanced head and neck cancer

The Effectiveness and Prognostic Factors of CT-guided Radioactive Iodine-125 Seed Implantation for the Treatment of Recurrent Head and Neck Cancer after External Beam Radiotherapy.

Clinical effectiveness of 125I-seed implantation in combination with nimotuzumab therapy for the advanced oral carcinoma: preliminary results

Permanent Implantation of Iodine-125 Seeds As a Salvage Therapy for Recurrent Head and Neck Carcinoma after Radiotherapy

Clinical Research of 125I Seeds Implantation Combined with Chemotherapy in the Treatment of Middle-Late Stage Non-Small Cell Lung Cancer

Implantation of Iodine-125 Seed for Head and Neck Carcinoma

Percutaneous Computed Tomography/ultrasonography-Guided Permanent Iodine-125 Implantation As Salvage Therapy for Recurrent Squamous Cell Cancers of Head and Neck

Computed Tomography Fluoroscopy-Guided Percutaneous 125I Seed Implantation for Safe, Effective and Real-Time Monitoring Radiotherapy of Inoperable Stage T1-3N0M0 Non-Small-cell Lung Cancer.

[Ct-Guidance Interstitial Iodine-125 Seed Brachytherapy As a Salvage Therapy for Recurrent Head and Neck Carcinoma].

Preliminary Clinical Efficacy of Iodine-125 Seed Implantation for the Treatment of Advanced Malignant Lung Tumors

Brachytherapy by Percutaneous Paracentesis Implantation of Iodine-125 Seeds for Lung Cancer

Therapeutic Effect of CT-guided 125I Seed Implantation on Advanced Lung Cancer and Pulmonary Metastatic Carcinoma

[Short- to Mid-Term Evaluation of CT-guided 125I Brachytherapy on Recurrent or Metastatic Head and Neck Cancers].

Combined External Radiotherapy and 125I-Particle Implantation for Treatment of Head and Neck Cancers

Efficacy of radioactive 125I seed implantation in treating inoperable or refused operation head and neck cancers

Permanent Implantation of 125I Seeds As a Salvage Therapy for Head and Neck Carcinoma after Radiotherapy